[DRAFT — Pending medical + legal review]   Every claim on this page requires medical director + healthcare counsel sign-off before publication.
(702) 555-0100 Book Consultation
Home/ Peptide Library/ Sermorelin
Andropause & Hormones  ·  Muscle, Strength & Body Composition  ·  Energy & Fatigue  ·  Healthy Aging & Longevity  ·  Sleep & Recovery

Sermorelin

GRF 1-29

A compounded growth-hormone-releasing hormone (GHRH) analog that some providers use as part of a broader plan supporting the growth-hormone axis in eligible adults.

Baseline Labs Required Compounded Subcutaneous injection (typically nightly) Prescription Consultation Required
Provider approval and a live video consultation are required before treatment. Schedule now →

What Is It?

Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of endogenous growth-hormone-releasing hormone (GHRH). It stimulates the pituitary to release growth hormone in a pulsatile, physiologic pattern. Sermorelin was previously available as an FDA-approved product (Geref) that has since been discontinued; today it is dispensed in the United States as a compounded prescription. Some providers use sermorelin as part of a broader plan intended to support body composition, sleep quality, or recovery in eligible adults with age-related decline in growth-hormone signaling, though it is not a replacement for FDA-approved therapies and requires careful provider oversight.

What May It Support?

  • Body composition support
  • Sleep quality (being evaluated)
  • Recovery from exercise (being evaluated)
  • Adjunctive support in a broader hormone-optimization plan

Which Programs May Include It?

Where It Fits

Binds pituitary GHRH receptors to stimulate endogenous growth hormone release in a pulsatile, physiologic pattern.

Beginner
Provider-directed use
Intermediate
Provider-directed use
Advanced
Provider-directed use

Do I Need Bloodwork?

Baseline Labs Required

Regular follow-up with periodic IGF-1 and metabolic labs at intervals determined by the provider.

Likely baseline panel may include: CBC, CMP, A1c, Lipid panel, IGF-1, TSH, Free T4, Pregnancy test when applicable

Important Safety Information

Common side effects may include:

  • Injection-site reactions
  • Flushing
  • Headache
  • Nausea
  • Vivid dreams
  • Water retention
Serious WarningsMay increase IGF-1; excess IGF-1 signaling has been associated with cancer risk
May contribute to fluid retention or joint discomfort
May affect glucose metabolism

Drug interactions: May interact with corticosteroids, thyroid hormone, and medications that affect glucose metabolism. Provider should review the complete medication list.

Contraindications:

  • Active malignancy
  • Disruption of the hypothalamic-pituitary axis
  • Pregnancy or breastfeeding
  • Known hypersensitivity to sermorelin or any product component
Pregnancy & BreastfeedingNot recommended during pregnancy, while trying to conceive, or while breastfeeding.
Cancer-Related ConsiderationsNot for patients with active malignancy. Any personal or family history of cancer should be disclosed to your provider before considering this therapy because sermorelin can raise IGF-1.

Regulatory Status

The previously FDA-approved sermorelin product (Geref) has been discontinued. Sermorelin is now dispensed in the United States as a compounded prescription and is not FDA-approved in its current form.

Compounded MedicationCompounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing.

Frequently Asked Questions

Is sermorelin growth hormone?
No. Sermorelin does not contain growth hormone. It stimulates the pituitary to release the body's own growth hormone in a pulsatile pattern.
Do I need bloodwork before starting?
Yes. Baseline labs, including IGF-1, are required so your provider can assess suitability and monitor safely.
How is sermorelin taken?
When prescribed, sermorelin is typically given as a subcutaneous injection at bedtime. Dose and duration are determined by the treating provider.
Can I take sermorelin if I have a history of cancer?
Sermorelin is contraindicated in patients with active cancer. Any personal or family cancer history must be reviewed by your provider before this therapy is considered.

Consultation

Treatment is not automatically provided. A licensed medical provider must review your history, symptoms, medications, laboratory results, and treatment goals before determining eligibility.

Schedule My Video Consultation
Explore More

Not sure where to start?

Answer a short set of questions about your goals and health history and see educational Beginner, Intermediate, and Advanced pathways your provider may discuss with you.

Not Medical Advice

The information provided on this website is for general educational purposes and is not medical advice, a diagnosis, or a prescription. Treatment recommendations are not final until a licensed medical provider completes a live consultation, reviews your medical history and medications, evaluates relevant laboratory results, and determines that treatment is medically appropriate.

Compounded Medication Disclosure

Certain treatments may be prepared by a compounding pharmacy pursuant to an individual prescription. Compounded medications are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing.

Results

Your results identify subjects to discuss with a provider. They do not establish medical eligibility or guarantee that any medication will be prescribed.

Emergencies

This website is not intended for emergencies. Call 911 or seek immediate medical attention for urgent or severe symptoms.